Lv7
3430 积分 2020-07-28 加入
Structure-Based Design of a Novel Covalent 4-(1-Methylindol-3-yl)pyrimidin-2-amine Series Targeting FGFR2 Resistance Mutations
4天前
已完结
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
8天前
已完结
The evolution of the obesity drug market
3个月前
已完结
The expanding benefits of GLP-1 medicines
3个月前
已完结
Chinese expert consensus on flow cytometric detection of hematological malignant cells in tissue samples
3个月前
已完结
Current LC-MS-based strategies for characterization and quantification of antibody-drug conjugates
3个月前
已完结
A Novel Dual-Payload ADC Platform Integrating Exatecan and Triptolide to Enhance Antitumor Efficacy and Overcome Resistance
3个月前
已完结
Development and optimization of a high-throughput LC-MS/MS method for the simultaneous determination of Exatecan and its Cathepsin B-sensitive prodrug, and ARV-825 in rat plasma: Application to pharmacokinetic study
3个月前
已完结
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
4个月前
已完结
ADCs or: How I Learned to Stop Worrying and Love Chemotherapy
4个月前
已完结
皖公网安备34019202002308
